Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA

Vaccine

Volumn 19, Issue 28-29, 2001, Pages 4028-4035

  Mollenkopf, Hans Joachim ^a   Groine Triebkorn, Daniela ^a   Andersen, Peter ^b   Hess, Juergen ^c   Kaufmann, Stefan H E ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b TB Research Unit   (Denmark)

^c November AG   (Germany)

Author keywords

ESAT 6; Mycobacterium tuberculosis; Vaccination

Indexed keywords

AMPICILLIN; BCG VACCINE; DNA VACCINE; HEMOLYSIN; ISONIAZID; LIVE VACCINE; RIFAMPICIN; SALMONELLOSIS VACCINE; SALMONELLOSIS VACCINE ESAT 6; SL 7207; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; BCG VACCINATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ESCHERICHIA COLI; FEMALE; GENE CONSTRUCT; GENE EXPRESSION SYSTEM; LIGATION; LUNG; LYMPHOCYTE PROLIFERATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SALMONELLA TYPHIMURIUM; TUBERCULOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; BCG VACCINE; DNA PRIMERS; FEMALE; GENETIC VECTORS; HUMANS; IMMUNIZATION, SECONDARY; INTERFERON TYPE II; LUNG; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MYCOBACTERIUM TUBERCULOSIS; RECOMBINANT PROTEINS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES; TUBERCULOSIS, PULMONARY; VACCINES, DNA;

EID: 0035898950     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(01)00109-8     Document Type: Article

References (34)

1. Nouvelles recherches experimentales sur la vaccination des bovides contre la tuberculose
2. Is the development of a new tuberculosis vaccine possible?
3. DNA vaccines
4. Live salmonella as vaccines and carriers of foreign antigenic determinants
5. Live attenuated salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens
6. Superior efficacy of secreted over somatic antigen display in recombinant salmonella vaccine induced protection against listeriosis
7. Conversion of bacterial gene products to secretion-competent fusion proteins
8. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
9. A historical and molecular phylogeny of BCG strains
10. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis
11. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG
12. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice
13. Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle
14. Comparison of antigen-specific T-cell responses of tuberculosis patients using complex or single antigens of Mycobacterium tuberculosis
15. Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors
16. Delayed-type hypersensitivity responses to ESAI-6 and MPT64 from Mycobacterium tuberculosis in the guinea pig
17. Differentiation between Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle by using recombinant mycobacterial antigens
18. ESAT-6 subunit vaccination against Mycobacterium tuberculosis
19. Extracellular PagC-HlyAs fusion protein for the generation and identification of salmonella-specific antibodies
20. Comparative proteome analysis of Mycobacterium tuberculosis and Mycobacterium bovis BCG strains: Towards functional genomics of microbial pathogens
21. Influence of mouse strain and vaccine viability on T-cell responses induced by Mycobacterium bovis bacillus Calmette-Guerin
22. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis
23. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun
24. Immunity to mycobacteria with emphasis on tuberculosis: Implications for rational design of an effective tuberculosis vaccine
25. The T cell response to secreted antigens of Mycobacterium tuberculosis
26. The significance of proteins actively secreted by Mycobacterium tuberculosis in relation to immunity and complications of mycobacterial diseases
27. Immunity to mycobacteria
28. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis
29. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences
30. Protection against tuberculosis by a plasmid DNA vaccine
31. Disseminated tuberculosis in interferon gamma gene-disrupted mice
32. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis
33. Role of cytokines in tuberculosis
34. Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG